import streamlit as st
from transformers import pipeline, AutoTokenizer, AutoModelForSequenceClassification
import pandas as pd
import numpy as np

# Load the fine-tuned model and tokenizer
tokenizer = AutoTokenizer.from_pretrained("slachitoff/CS-GY_6613_Milestone_3")
model = AutoModelForSequenceClassification.from_pretrained("slachitoff/CS-GY_6613_Milestone_3")

# Define the app layout
st.set_page_config(page_title="Patentability Classifier App")
st.title("Patentability Classifier")
st.markdown("Enter the Patent ID, abstract and claims:")

# Define SessionState to store patent scores and ideas within the session
class SessionState:
    def __init__(self):
        self.patentData = {
            "9950112": {
                "abstract": "The present invention relates to a method of preparing a peptide comprising the amino acid sequence His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO:1). In particular, the method comprises the steps of providing a first peptide fragment having a first protection group, which peptide fragment is conjugated to a support; providing a second peptide fragment having a second protection group; removing the first protection group from the first peptide fragment; and coupling the second peptide fragment to the N-terminally deprotected, support-conjugated first peptide fragment. The present invention further relates to a method of preparing a pharmaceutical composition containing said peptide.",            "claims": "A medication or fluid delivery and control system comprising: (a) at least one apparatus comprising at least one sensor for measuring pharmacodynamic (PD), pharmacokinetic (PK), or both PD and PK parameters in a subject; (b) an infusion device with a rate of infusion which is increased, decreased, or maintained at a given level of infusion based on said PD, PK, or both parameters; and (c) a controller for receiving said PD, PK or both PD and PK parameters and, based on said parameters, increasing, decreasing or maintaining the rate of infusion of said infusion device. 2. The medication or fluid delivery and control system according to claim 1 in which a photoplethysmographic signal is utilized to derive information on the PD and/or PK status of a subject and to control infusion rate in a closed-loop or an open-loop system. 3. The medication or fluid delivery and control system according to claim 2 wherein said photoplethysmographic signal is obtained from the subject's nasal ala as a Single Point of Contact (SPOC) device. 4. The medication or fluid delivery and control system according to claim 1 further comprising any one or a combination of the following elements: 1. a battery pack or access to existing power in the warfighter ensemble 1/1; 2. an accelerometer or other motion sensing device 1/2 worn on the helmet of a subject 1/3 or other location on the head (e.g. behind the subject's ear) which provides signals indicating whether a warfighter is actively moving or is inactive to provide a \u201cwake-up\u201d signal to the sensing system 1/4 so that it may remain in a standby status until needed; 3. at least one, and preferably two SPOC sensor assemblies 3/300 each containing pulse oximeter components (LEDs [photodiodes] 3/301 and photodetector 3/302), nasal pressure or flow sensors, 3/304, optionally, one of two ECG electrodes, 3/305 (the other to be placed in the undergarments or on the torso of the warfighter); 4. means to fix the SPOC sensors securely to the subject, selected from the group consisting of retainer device, 3/306, which fits over the bridge of the subject's nose and/or up to the helmet or other fixation point on the forehead, for example, using a headband, 3/307, wherein the forehead band, 3/307, communications ensemble or the helmet optionally contain reservoirs of medications and or fluids, 3/308, (3/308A, 3/308B, 3/308C, 3/308D, represent separate reservoirs with same or different fluids/medications), each of which is linked (via communication lines 3/308a, 3/308b, 3/308c, 3/308d to and activated for release of fluid/medications by the computer/CPU 3/320 which controls the closed-loop system, and other components/sensors of the system; such that said computer/CPU, 3/320, receives signals, 3/321, from the PD, PK or PD+PK sensors 3/301, 3/302, 3/305, affixed to the subject via communication line(s) 3/301a, 3/302a, 3/305a; 5. a medication or fluid delivery system selected from: a small tube, 3/303, incorporated into the assembly and for emplacement inside the subject's nostril for orientation toward the nasal septum (nasal epithelium/mucosa) which delivers aerosols and/or non-aerosols of pre-metered doses of medications (e.g. opioids, anxiolytics, steroids, vasoactive drugs, and the like); or in alternate configurations, the delivery device comprises a needle/catheter for insertion subcutaneously, rectally, intravenously, intraperitoneally, intraarterially, intracardiacly, intraosseously; 6. where utilized, the intranasal tube, 3/303, or other medication or fluid delivery system connected to a drug delivery system capable of providing aerosolized and/or non-aerosolized medication through the nasal epithelium delivery tube 3/303, said aerosolized and/or non-aerosolized medication(s) optionally stored in pressurized canisters, 3/308, adapted to provide metered doses upon actuation of a valve or a small pump that delivers aerosolized and/or non-aerosolized doses from a given container, 3/308, via delivery line(s) 3/309 connected to said nasal epithelium delivery tube 3/303; 7. optionally, nitric oxide, histamine, methacholine included in the medication delivery system, either as part of the medication compositions or as a separate feed to the nasal mucosa, to increase permeability of the nasal mucosa to the delivered medications; 8. highly concentrated doses of opioids (fentanyl, sufentanyl); opioid antagonists (naltrexone/naloxone for \u201crecovery\u201d if too large a dose of opioids is delivered); vasoactive drugs, particularly vasopressin; steroids (dexamethasone); dissociative agents such as ketamine; anxiolytics (benzodiazepines, gabapentin, pregabalin), included as single component compositions which are separately deliverable to a subject in need of such agents, based on measurements of their PD parameters, provided via separate infusion lines to the subject or may be combined for delivery through a single line; 9. canisters or containers for medications and fluids, 3/308, adapted so that they can be removably but securely inserted into the system (e.g. canisters or container that can be snapped into the system by engaging clips and holding compartments adapted for protection and engagement of such canisters or containers) so that different medication combinations can be provided; 10. a small central processing unit (CPU), 2/210, 3/320, including algorithms/software stored in RAM, 2/220, and/or ROM, 2/230m facilitate closed-loop (servo) delivery of medications and control of the medical devices (sensors and infusion mechanics); 11. small infusion pumps (e.g. ambIT PCA pump, http://www.ambitpump.com), 3/321, deliver volume expanders (hypertonic saline; dextrans) via subcutaneous, intraosseous, or IV routes when available; 12. a second \u201cperipheral\u201d pulse oximeter sensor to provide information on volume status, or the status of an injured extremity; 13. nasal pressure/flow sensors, 3/304, and/or PPG sensors, 3/301, 3/302, utilized to detect phase of respiration and meter doses of medication only during the inspiratory phase; said system to operate as a complete autonomous care by the warfighter, or with the assistance of other warfighters in the combat zone, by emplacing the SPOC sensor assembly if the warfighter is unconscious or unable to apply the assembly to him/herself; or comprising remote communication of the vital sign information and control of the WARCARE\u2122 system once the SPOC is emplaced. 5. The system according to claim 4 wherein said system optionally remains in place as the warfighter is transferred to higher levels of medical care for both monitoring and drug therapy, and, wherein, once IV access is obtained, drug delivery can be switched to this route with said WARCARE\u2122 system optionally remaining in place through all levels of medical care and it being adapted to interface with other medical treatment and monitoring systems. 6. The system according to claim 5, wherein the WARCARE\u2122 assembly is in place as in integral part of the combatant's helmet and/or telemetry/communications gear. 7. The system according to claim 5 wherein the WARCARE\u2122 system delivers medications in a timely manner through nasal epithelium. 8. The system according to claim 5 wherein said accelerometer or like motion and/or orientation detection sensor, monitors whether a warfighter is actively moving or has suddenly ceased to move, or is used to limit the power consumption of the WARCARE\u2122 system by maintaining it in \u201csleep\u201d mode until it senses a sudden change in the war fighter's level of activity. 9. The system according to claim 8 wherein said accelerometer or like motion sensor is adapted to detect very regular but intense body movement indicative of seizure activity, and to the controller to provide a benzodiazepine or other antiseizure medications if the WARCARE\u2122 system is in place or once the SPOC assembly is emplaced by a fellow combatant. 10. A method for delivering medication or fluid to a subject comprising emplacing on said subject a delivery and control system comprising: (a) at least one apparatus comprising at least one sensor for measuring pharmacodynamic (PD), pharmacokinetic (PK), or both PD and PK parameters in a subject; (b) an infusion device with a rate of infusion which is increased, decreased, or maintained at a given level of infusion based on said PD, PK, or both parameters; and (c) a controller for receiving said PD, PK or both PD and PK parameters and, based on said parameters, increasing, decreasing or maintaining the rate of infusion of said infusion device. 11. The method according to claim 10, said delivery control system further comprising any one or a combination of the following elements: 1. a battery pack or access to existing power in the warfighter ensemble 1/1; 2. an accelerometer or other motion sensing device 1/2 worn on the helmet of a subject 1/3 or other location on the head (e.g. behind the subject's ear) which provides signals indicating whether a warfighter is actively moving or is inactive to provide a \u201cwake-up\u201d signal to the sensing system 1/4 so that it may remain in a standby status until needed; 3. at least one, and preferably two SPOC sensor assemblies 3/300 each containing pulse oximeter components (LED photodiodes 3/301 and photodetector 3/302), nasal pressure/flow sensors, 3/304, optionally, one of two ECG electrodes, 3/305 (the other to be placed in the undergarments or on the torso of the warfighter); 4. means to fix the SPOC sensors securely to the subject, selected from the group consisting of retainer device, 3/306, which fits over the bridge of the subject's nose and/or up to the helmet or other fixation point on the forehead, for example, using a headband, 3/307, wherein the forehead band, 3/307, communications ensemble or the helmet optionally contain reservoirs of medications and or fluids, 3/308, (3/308A, 3/308B, 3/308C, 3/308D, represent separate reservoirs with same or different fluids/medications), each of which is linked (via communication lines 3/308a, 3/308b, 3/308c, 3/308d to and activated for release of fluid/medications by the computer/CPU 3/320 which controls the closed-loop system, and other components/sensors of the system; such that said computer/CPU, 3/320, receives signals, 3/321, from the PD, PK or PD+PK sensors 3/301, 3/302, 3/305, affixed to the subject via communication line(s) 3/301a, 3/302a, 3/305a; 5. a medication or fluid delivery system selected from: a small tube, 3/303, incorporated into the assembly and for emplacement inside the subject's nostril for orientation toward the nasal septum (nasal epithelium) which delivers aerosols and/or non-aerosols of pre-metered doses of medications (e.g. opioids, anxiolytics, steroids, vasoactive drugs, and the like); or in alternate configurations, the delivery device comprises a needle for insertion intravenously, intraperitoneally, intracardiacly; 6. where utilized, the intranasal tube, 3/303, or other medication or fluid delivery system connected to a drug delivery system capable of providing aerosolized and/or non-aerosolized medication through the nasal epithelium delivery tube 3/303, said aerosolized and/or non-aerosolized medication(s) optionally stored in pressurized canisters, 3/308, adapted to provide metered doses upon actuation of a valve or a small pump that delivers aerosolized and/or non-aerosolized doses from a given container, 3/308, via delivery line(s) 3/309 connected to said nasal epithelium delivery tube 3/303; 7. optionally, nitric oxide, histamine, methacholine included in the medication delivery system, either as part of the medication compositions or as a separate feed to the nasal mucosa, to increase permeability of the nasal mucosa to the delivered medications; 8. highly concentrated doses of opioids (fentanyl, sufentanyl); opioid antagonists (naltrexone/naloxone for \u201crecovery\u201d if too large a dose of opioids is delivered); vasoactive drugs, particularly vasopressin; steroids (dexamethasone); dissociative agents such as ketamine; anxiolytics (benzodiazepines, gabapentin, pregabalin), included as single component compositions which are separately deliverable to a subject in need of such agents, based on measurements of their PD parameters, provided via separate infusion lines to the subject or may be combined for delivery through a single line; 9. canisters or containers for medications and fluids, 3/308, adapted so that they can be removably but securely inserted into the system (e.g. canisters or container that can be snapped into the system by engaging clips and holding compartments adapted for protection and engagement of such canisters or containers) so that different medication combinations can be provided; 10. a small central processing unit (CPU), 2/210, 3/320, including algorithms/software stored in RAM, 2/220, and/or ROM, 2/230m facilitate closed-loop (servo) delivery of medications and control of the medical devices (sensors and infusion mechanics); 11. small infusion pumps (e.g. ambIT PCA pump, http://www.ambitpump.com), 3/321, deliver volume expanders (hypertonic saline; dextrans) via subcutaneous, intraosseous, or IV routes when available; 12. a second \u201cperipheral\u201d pulse oximeter sensor to provide information on volume status, or the status of an injured extremity; 13. nasal pressure sensors, 3/304, and/or PPG sensors, 3/301, 3/302, utilized to detect phase of respiration and meter doses of medication only during the inspiratory phase; said system to operate as a complete autonomous care by the warfighter, or with the assistance of other warfighters in the combat zone, by emplacing the SPOC sensor assembly if the warfighter is unconscious or unable to apply the assembly to him/herself; or comprising remote communication of the vital sign information and control of the WARCARE\u2122 system once the SPOC is emplaced. 12. The method according to claim 10 to minimize morbidity, mortality, PTSD, TBI, in an injured warfighter which comprises providing to said warfighter, prior to injury, a self-contained system which (i) obtains measurements of the warfighter's vital signs selected from the group consisting of nasal pressure/flow, electrocardiographic signals, blood pressure, heart rate, arrhythmias, respiratory rate, respiratory effort indicative of work of breathing, inspiratory and expiratory breathing ratios (I:E ratios) and patterns of each indicative of normal respiratory or respiratory depression, blood oxygen content, pulse oximetry (SpO2), blood volume measurements including local arterial blood flow amplitude, venous capacitance and comparative flows and capacitance from two or more site indicative of hypovolemia/shock and/or loss of extremity perfusion, pulse transit time, pulse wave velocity and combinations thereof, (ii) processes said measurements to determine the relative state of health or otherwise of the warfighter and, based on said determination, (iii) infuses appropriate medications and fluids into the warfighter in the field as appropriate to the state of health or otherwise of said warfighter. 13. An apparatus comprising: (a) at least one apparatus comprising at least one sensor for measuring pharmacodynamic (PD), pharmacokinetic (PK), or both PD and PK parameters in a subject; (b) an infusion device with a rate of infusion which is increased, decreased, or maintained at a given level of infusion based on said PD, PK, or both parameters; and (c) a controller for receiving said PD, PK or both PD and PK parameters and, based on said parameters, increasing, decreasing or maintaining the rate of infusion of said infusion device. 14. The apparatus according to claim 13 further comprising any one or a combination of the following elements: 1. a battery pack or access to existing power in the warfighter ensemble 1/1; 2. an accelerometer or other motion sensing device 1/2 worn on the helmet of a subject 1/3 or other location on the head (e.g. behind the subject's ear) which provides signals indicating whether a warfighter is actively moving or is inactive to provide a \u201cwake-up\u201d signal to the sensing system 1/4 so that it may remain in a standby status until needed; 3. at least one, and preferably two SPOC sensor assemblies 3/300 each containing pulse oximeter components (LED 3/301 and photodiode 3/302), nasal pressure sensors, 3/304, optionally, one of two ECG electrodes, 3/305 (the other to be placed in the undergarments or on the torso of the warfighter); 4. means to fix the SPOC sensors securely to the subject, selected from the group consisting of retainer device, 3/306, which fits over the bridge of the subject's nose and/or up to the helmet or other fixation point on the forehead, for example, using a headband, 3/307, wherein the forehead band, 3/307, communications ensemble or the helmet optionally contain reservoirs of medications and or fluids, 3/308, (3/308A, 3/308B, 3/308C, 3/308D, represent separate reservoirs with same or different fluids/medications), each of which is linked (via communication lines 3/308a, 3/308b, 3/308c, 3/308d to and activated for release of fluid/medications by the computer/CPU 3/320 which controls the closed-loop system, and other components/sensors of the system; such that said computer/CPU, 3/320, receives signals, 3/321, from the PD, PK or PD+PK sensors 3/301, 3/302, 3/305, affixed to the subject via communication line(s) 3/301a, 3/302a, 3/305a; 5. a medication or fluid delivery system selected from: a small tube, 3/303, incorporated into the assembly and for emplacement inside the subject's nostril for orientation toward the nasal septum (nasal epithelium) which delivers aerosols and/or non-aerosols of pre-metered doses of medications (e.g. opioids, anxiolytics, steroids, vasoactive drugs, and the like); or in alternate configurations, the delivery device comprises a needle for insertion intravenously, intraperitoneally, intracardiacly; 6. where utilized, the intranasal tube, 3/303, or other medication or fluid delivery system connected to a drug delivery system capable of providing aerosolized and/or non-aerosolized medication through the nasal epithelium delivery tube 3/303, said aerosolized and/or non-aerosolized medication(s) optionally stored in pressurized canisters, 3/308, adapted to provide metered doses upon actuation of a valve or a small pump that delivers aerosolized and/or non-aerosolized doses from a given container, 3/308, via delivery line(s) 3/309 connected to said nasal epithelium delivery tube 3/303; 7. optionally, nitric oxide, histamine, methacholine included in the medication delivery system, either as part of the medication compositions or as a separate feed to the nasal mucosa, to increase permeability of the nasal mucosa to the delivered medications; 8. highly concentrated doses of opioids (fentanyl, sufentanyl); opioid antagonists (naltrexone/naloxone for \u201crecovery\u201d if too large a dose of opioids is delivered); vasoactive drugs, particularly vasopressin; steroids (dexamethasone); dissociative agents such as ketamine; anxiolytics (benzodiazepines, gabapentin, pregabalin), included as single component compositions which are separately deliverable to a subject in need of such agents, based on measurements of their PD parameters, provided via separate infusion lines to the subject or may be combined for delivery through a single line; 9. canisters or containers for medications and fluids, 3/308, adapted so that they can be removably but securely inserted into the system (e.g. canisters or container that can be snapped into the system by engaging clips and holding compartments adapted for protection and engagement of such canisters or containers) so that different medication combinations can be provided; 10. a small central processing unit (CPU), 2/210, 3/320, including algorithms/software stored in RAM, 2/220, and/or ROM, 2/230m facilitate closed-loop (servo) delivery of medications and control of the medical devices (sensors and infusion mechanics); 11. small infusion pumps (e.g. ambIT PCA pump, http://www.ambitpump.com), 3/321, deliver volume expanders (hypertonic saline; dextrans) via subcutaneous, intraosseous, or IV routes when available; 12. a second \u201cperipheral\u201d pulse oximeter sensor to provide information on volume status, or the status of an injured extremity; 13. nasal pressure sensors, 3/304, and/or PPG sensors, 3/301, 3/302, utilized to detect phase of respiration and meter doses of medication only during the inspiratory phase; said system to operate as a complete autonomous care by the warfighter, or with the assistance of other warfighters in the combat zone, by emplacing the SPOC sensor assembly if the warfighter is unconscious or unable to apply the assembly to him/herself; or comprising remote communication of the vital sign information and control of the WARCARE\u2122 system once the SPOC is emplaced. 15. The Single Point of Contact (SPOC) system according to claim 3 comprising a PD, PK, or PD and PK acquisition subsystem for emplacement on a subject, a controller unit for receiving signals from said PD, PK, or PD and PK acquisition subsystem and for processing said signals and, on the basis of such processing, controlling the delivery of agents to the subject and an agent delivery subsystem. 16. The SPOC system according to claim 15 in which any or a combination of the following elements is included: a. the PD acquisition subsystem comprises at least one sensor selected from the group consisting of a nasal pressure sensor, a PPG sensor, ECG sensor and combinations thereof; b. the agent delivery subsystem is physically integral with the PD acquisition subsystem, wherein said agent delivery subsystem comprises a fluid or gas channel for delivery of agent to the nasal epithelium and said PD acquisition subsystem comprises a PPG and a nasal pressure sensor."
            },
            "9604242": {
                "abstract": "A volatile liquid droplet dispenser for containing a liquid to be dispensed, with a first substrate having a space for containing the liquid, and having an outlet With at least one outlet nozzle, the first substrate further having the space adjacent to the liquid outlet, to receive the liquid such that the liquid may exit through at least one outlet nozzle of the outlet, a second substrate having a liquid inlet, and an actuating membrane arranged to actuate liquid in the space. The first substrate also has a fluidic channel interconnected to the space and arranged to laterally connect the liquid inlet means to the space, thereby conveying the liquid to the space by way of lateral capillary action. The outlet is eccentric to the liquid inlet and in a vertical plane that is substantially the same or lower than the plane of the liquid inlet, depending on the liquid used.",
                "claims": "Volatile liquid droplet dispenser device for containing a liquid substance to be dispensed, the device comprising: a first substrate having a space for containing said liquid substance, and having liquid outlet means, said liquid outlet means comprising at least one outlet nozzle for ejecting liquid substance there through, said first substrate further having said space arranged proximate to said liquid outlet means and to receive said liquid substance such that said liquid substance may exit the space of the device by traversing said at least one outlet nozzle of said liquid outlet means; a second substrate having a liquid inlet means for allowing said liquid substance to enter said device; an actuating membrane arranged to actuate liquid substance in said space such that the liquid substance undergoes a vibration and contacts the liquid outlet means thereby exiting said device as a liquid droplet spray, wherein said first substrate further comprises a fluidic channel interconnected to said space and arranged to laterally connect said liquid inlet means to said space thereby conveying said liquid substance to said space by way of lateral capillary action; and said liquid outlet means is arranged eccentric to said liquid inlet means and in a vertical plane that is substantially the same or lower than the plane of the liquid inlet means depending on liquid substance properties. 2. Volatile liquid droplet dispenser device according to claim 1, further comprising a first reservoir for containing said liquid substance. 3. Volatile liquid droplet dispenser device according to claim 2, wherein said first reservoir is an external reservoir, and wherein said first substrate or said second substrate further comprises connection means arranged to receive said external reservoir. 4. Volatile liquid droplet dispenser device according to claim 2, wherein said first reservoir is an internal reservoir integrated into said volatile liquid droplet dispenser device. 5. Volatile liquid droplet dispenser device according to claim 1, wherein said first substrate has a recess in a first main surface, which constitutes a space for containing said liquid substance. 6. Volatile liquid droplet dispenser device according to claim 4, wherein said first substrate has a recess in a first main surface, which constitutes a space for containing said liquid substance; and wherein said space is arranged to contain said internal reservoir. 7. Volatile liquid droplet dispenser device according to claim 5, wherein said first substrate further has a through hole traversing said recess and the other main surface of said first substrate, and wherein said liquid outlet means are arranged in said through hole so as to delimit said recess in said first main surface thus closing said through hole. 8. Volatile liquid droplet dispenser device according to claim 1, wherein said actuating membrane is arranged in between the first and second substrates and delimits said space. 9. Volatile liquid droplet dispenser device according to claim 1, wherein said liquid outlet means has a nozzle body including a thicker main section and a thinner membrane section, said thinner membrane section comprising said at least one outlet nozzle. 10. Volatile liquid droplet dispenser device according to claim 1, wherein said liquid outlet means consists of a flat substrate comprising said at least one outlet nozzle. 11. Volatile liquid droplet dispenser device according to claim 1, further comprising a programmable microcontroller for controlling said actuating membrane by varying an operating frequency, and by varying a supply voltage, wherein the operating frequency range and the supply voltage are chosen to correspond to a range of viscosities and a particular droplet size. 12. Volatile liquid droplet dispenser device according to claim 1, wherein said fluidic channel comprises a wick. 13. Volatile liquid droplet dispenser device according to claim 1, wherein said fluidic channel is a metal plate. 14. Volatile liquid droplet dispenser device according to claim 5, wherein said fluidic channel contains a plurality of micro-channels arranged in the first main surface of said first substrate. 15. Volatile liquid droplet dispenser device according to claim 1, wherein said fluidic channel also comprises a buffer reservoir. 16. Volatile liquid droplet dispenser device according to claim 1, wherein said liquid inlet means comprises a wick. 17. Volatile liquid droplet dispenser device according to claim 3, wherein said liquid inlet means is a tube arranged to extend into the external reservoir. 18. Volatile liquid droplet dispenser device according to claim 1, wherein said actuating membrane is formed of a first part and a second part that are arranged in a slideable arrangement with respect to each other. 19. Volatile liquid droplet dispenser device according to claim 3, wherein said external reservoir comprises a collapsible bag linked to said liquid inlet means. 20. Volatile liquid droplet dispenser device according to claim 1, further comprising a venting means. 21. Volatile liquid droplet dispenser device according to claim 11, further comprising a venting means; and wherein said programmable microcontroller is further arranged to actuate said actuating membrane in a bubble-eliminating mode for driving any air bubbles contained in the liquid substance towards said venting means by applying bursts at a frequency of a few to several times higher than the normal operating frequency and with a duration from under 1 second to several seconds. 22. (canceled) 23. Apparatus comprising a volatile droplet dispenser device according to claim 1, wherein said apparatus is selected from the group of a vacuum-cleaner, a floor cleaner, robotics to clean a room, an aromatherapy apparatus, a respiratory therapy apparatus, an air-freshener, a fragrancer, an air purifier, an air conditioner, an insecticide dispensing apparatus, an ironing machine, a white goods appliance or an individual communication apparatus.",
            },
            "9660732": {
                "abstract": "It is disclosed an optical coherent receiver for an optical communication network. The optical coherent receiver is configured to receive a modulated optical signal and to process it for generating an in-phase component and a quadrature component. The optical coherent receiver comprises a power adjuster in turn comprising a multiplying unit and a retroactively connected digital circuit. The multiplying unit is configured to multiply the in-phase and quadrature components by in-phase and quadrature gains, respectively, thereby providing power-adjusted in-phase and quadrature components. The digital circuit is configured to compute: a common gain indicative of a sum of the powers of the power-adjusted in-phase and quadrature components; a differential gain indicative of a difference between the powers of the power-adjusted in-phase and quadrature components; and the in-phase and quadrature gains as a product and a ratio, respectively, between the common gain and the differential gain.",
                "claims": "An optical coherent receiver for an optical communication network, said optical coherent receiver being configured to receive a modulated optical signal and to process said modulated optical signal for generating an in-phase component and a quadrature component, said in-phase component and said quadrature component being electrical signals, said optical coherent receiver comprising a power adjuster in turn comprising: a multiplying unit configured to multiply said in-phase component by an in-phase gain thereby providing a power-adjusted in-phase component, and to multiply said quadrature component by a quadrature gain thereby providing a power-adjusted quadrature component; and a digital circuit connected between output and input of said multiplying unit and configured to compute: a common gain indicative of a sum of a power of said power-adjusted in-phase component and a power of said power-adjusted quadrature component, and a differential gain indicative of a difference between said power of said power-adjusted in-phase component and said power of said power-adjusted quadrature component; and said in-phase gain as a product between said common gain and said differential gain, and said quadrature gain as a ratio between said common gain and said differential gain. 2. An optical coherent receiver according to claim 1, wherein it further comprises an analog-to-digital unit connected at the input of said power adjuster, said analog-to-digital unit being configured to sample said in-phase component and said quadrature component for providing N in-phase component and N quadrature component samples to said power adjuster at each clock cycle of a clock signal generated at said optical coherent receiver, N being an integer equal to or higher than 1. 3. An optical coherent receiver according to claim 2, wherein said multiplying unit is a digital unit configured to multiply said N in-phase component samples by said in-phase gain thereby providing N power-adjusted in-phase component samples, and to multiply said N quadrature component samples by said quadrature gain thereby providing N power-adjusted quadrature component samples. 4. An optical coherent receiver according to claim 1, wherein said multiplying unit is an analog unit. 5. An optical coherent receiver according to claim 4, wherein said power adjuster comprises an analog-to-digital unit connected at the output of said multiplying unit, said analog-to-digital unit being configured to sample said power-adjusted in-phase component and said power-adjusted quadrature component for providing N power-adjusted in-phase component samples and N power-adjusted quadrature component samples at each clock cycle of a clock signal generated at said optical coherent receiver, N being an integer equal to or higher than 1. 6. An optical coherent receiver according to claim 3, wherein said digital circuit comprises a computation module configured to receive said N power-adjusted in-phase component samples and said N power-adjusted quadrature component samples and to calculate a common metric according to the following equation: c = \u2211 k = 0 N - 1 \ue89e \ue89e \uf603 I k \u2032 \uf604 2 + \uf603 Q k \u2032 \uf604 2 , c being said common metric, being said N power-adjusted in-phase component samples and Q\u2032k being said N power-adjusted quadrature component samples. 7. An optical coherent receiver according to claim 3, wherein said digital circuit comprises a computation module configured to receive said N power-adjusted in-phase component samples and said N power-adjusted quadrature component samples and to calculate a common metric according to the following equation: c = \u2211 k = 0 N - 1 \ue89e \ue89e ( \uf603 I k \u2032 \uf604 + \uf603 Q k \u2032 \uf604 2 + ( 1 - 1 2 ) \u00b7 \uf603 \uf603 I k \u2032 \uf604 - \uf603 Q k \u2032 \uf604 \uf604 ) , c being said common metric, I\u2032k being said N power-adjusted in-phase component samples and Q\u2032k being said N power-adjusted quadrature component samples. 8. An optical coherent receiver according to claim 6, wherein said digital circuit further comprises a cascade of an adder, a common multiplier and a common accumulator connected at the output of said computation module, wherein: said adder is configured to calculate c\u22122T, T being a target value that the power of said power-adjusted in-phase component and the power of said power-adjusted quadrature component should reach; said common multiplier is configured to calculate Sc\u00b7(c\u22122T), Sc being a common loop gain; and said common accumulator is configured to update its content (ac[n\u22121]) by adding Sc\u00b7(c\u22122T) to it, thereby providing an updated common content (ac[n]). 9. An optical coherent receiver according to claim 8, wherein said computation module is further configured to calculate a differential metric according to the following equation: d = \u2211 k = 0 N - 1 \ue89e ( \uf603 I k \u2032 \uf604 - \uf603 Q k \u2032 \uf604 ) , d being said differential metric, I\u2032k being said N power-adjusted in-phase component samples and Q\u2032k being said N power-adjusted quadrature component samples. 10. An optical coherent receiver according to claim 9, wherein said digital circuit further comprises a cascade of a differential multiplier and a differential accumulator connected at the output of said computation module, wherein: said differential multiplier is configured to calculate Sd\u00b7d, Sd being a differential loop gain; and said differential accumulator is configured to update its content (ad[n\u22121]) by adding Sd\u00b7d to it, thereby providing an updated differential content (ad[n]). 11. An optical coherent receiver according to claim 10, wherein said differential loop gain is lower than said common loop gain. 12. An optical coherent receiver according to claim 8, wherein said digital circuit further comprises an in-phase adder and a quadrature adder connected both to said common accumulator and to said differential accumulator, wherein: said in-phase adder is configured to provide a sum (ac[n]+ad[n]) of said updated common content (ac[n]) and said updated differential content (ac[n]); and said quadrature adder is configured to provide a difference (ac[n]\u2212ad[n]) between said updated common content (ac[n]) and said updated differential content (ac[n]). 13. An optical coherent receiver according to claim 12, wherein said digital circuit further comprises an in-phase exponential module connected between said in-phase adder and said multiplying unit and a quadrature exponential module connected between said quadrature adder and said multiplying unit, wherein: said in-phase exponential module is configured to calculate said in-phase gain as a negative exponential function of said sum; and said quadrature exponential module is configured to calculate said quadrature gain as a negative exponential function of said difference. 14. A node for a communication network comprising an optical coherent receiver, said optical coherent receiver being configured to receive a modulated optical signal and to process said modulated optical signal for generating an in-phase component and a quadrature component, said in-phase component and said quadrature component being electrical signals, said optical coherent receiver comprising a power adjuster in turn comprising: a multiplying unit configured to multiply said in-phase component by an in-phase gain thereby providing a power-adjusted in-phase component, and to multiply said quadrature component by a quadrature gain thereby providing a power-adjusted quadrature component; and a digital circuit connected between output and input of said multiplying unit and configured to compute: a common gain indicative of a sum of a power of said power-adjusted in-phase component and a power of said power-adjusted quadrature component, and a differential gain indicative of a difference between said power of said power-adjusted in-phase component and said power of said power-adjusted quadrature component; and said in-phase gain as a product between said common gain and said differential gain, and said quadrature gain as a ratio between said common gain and said differential gain. 15. A method for adjusting power of an in-phase component and a quadrature component of a modulated optical signal received at an optical coherent receiver for an optical communication network, said in-phase component and said quadrature component being electrical signals, said method comprising: multiplying said in-phase component by an in-phase gain thereby providing a power-adjusted in-phase component, and multiplying said quadrature component by a quadrature gain thereby providing a power-adjusted quadrature component; and computing: a common gain indicative of a sum of a power of said power-adjusted in-phase component and a power of said power-adjusted quadrature component, and a differential gain indicative of a difference between said power of said power-adjusted in-phase component and said power of said power-adjusted quadrature component; and said in-phase gain as a product between said common gain and said differential gain, and said quadrature gain as a ratio between said common gain and said differential gain."
            },
            "9782455": {
                "abstract": "The present invention relates to a method of preparing a peptide comprising the amino acid sequence His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO:1). In particular, the method comprises the steps of providing a first peptide fragment having a first protection group, which peptide fragment is conjugated to a support; providing a second peptide fragment having a second protection group; removing the first protection group from the first peptide fragment; and coupling the second peptide fragment to the N-terminally deprotected, support-conjugated first peptide fragment. The present invention further relates to a method of preparing a pharmaceutical composition containing said peptide.",
                "claims": "A method of preparing a peptide comprising the amino acid sequence His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO: 1), the method comprising the steps of: (a) providing a first peptide fragment comprising the amino acid sequence X-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO: 2), wherein X is a first protection group and wherein the C-terminal residue of the first peptide fragment is conjugated to a support; (b) providing a second peptide fragment comprising the amino acid sequence Y-His-Gly-Asp-Gly (SEQ ID NO: 3), wherein Y is a second protection group; (c) removing the first protection group from the first peptide fragment; and (d) coupling the second peptide fragment to the N-terminally deprotected, support-conjugated first peptide fragment. 2. The method of claim 1, wherein the first peptide fragment and/or the second peptide fragment are prepared by solid phase peptide synthesis, and wherein optionally, in case the second peptide fragment is prepared by solid phase synthesis, the second peptide fragment is cleaved from the support prior to coupling the second peptide fragment to the N-terminally deprotected first peptide fragment, and/or wherein optionally, in case the first peptide fragment is prepared by solid phase peptide synthesis, the first peptide fragment coupled to the second peptide fragment is cleaved from the support. 3. The method of claim 2, wherein the first peptide fragment and/or the second peptide fragment are provided by conjugating the C-terminal amino acid residue to a support and sequentially adding appropriately protected amino acids to the N-terminus of the C-terminal, support-conjugated residue(s). 4. The method of claim 3, wherein amino acids to be sequentially added to the N-terminus of the C-terminal, support-conjugated residue(s) of the first peptide fragment and/or the second peptide fragment are each protected by a protection group selected from the group consisting of Boc and Fmoc. 5. The method of claim 1, wherein the first protection group is Fmoc. 6. The method of claim 1, wherein the second protection group is an acid-labile protection group, selected from the group consisting of Boc and benzyloxycarbonyl. 7. The method of claim 1, wherein the histidine residue of the second peptide fragment is protected at the side chain with a protection group selected from the group consisting of trityl, Boc, Bom and Bum. 8. The method of claim 1, wherein the aspartic residue of the second peptide fragment is protected at the side chain with a tert-butyl ester protection group. 9. The method of claim 1, comprising: (a) providing by solid phase synthesis a first peptide fragment comprising the amino acid sequence X-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO: 2) by peptide synthesis, wherein X is a Fmoc protection group and wherein the C-terminal residue of the first peptide fragment is conjugated to a support; (b) providing by solid phase synthesis a second peptide fragment comprising the amino acid sequence Y-His-Gly-Asp-Gly (SEQ ID NO: 3) by peptide synthesis, wherein Y is an acid-labile protection group, selected from the group consisting of Boc and benzyloxycarbonyl, and wherein the C-terminal residue of the second peptide fragment is conjugated to a support; (c) cleaving the second peptide fragment from the support; (d) optionally purifying the cleaved second peptide fragment; (e) removing the Fmoc protection group from the first peptide fragment, by adding a secondary amine selected from the group consisting of piperidine, piperazine, morpholine and dicyclohexylamine; (f) coupling the second peptide fragment to the support-conjugated first peptide fragment by adding the purified second peptide fragment to the N-terminally deprotected, support-conjugated first peptide fragment; (g) cleaving the support-conjugated first peptide fragment coupled to the second peptide fragment from the support; and (h) optionally purifying the cleaved first peptide fragment coupled to the second peptide fragment. 10. The method of claim 9, wherein the C-terminal amino acid of the first peptide fragment and/or the second peptide fragment is attached to the functionalized polymer by means of a linker. 11. A method of preparing a pharmaceutical composition containing a peptide comprising the amino acid sequence His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp (SEQ ID NO: 1), the method comprising the steps of: (a) preparing the peptide according to the method of claim 1; and (b) preparing a pharmaceutical composition containing the peptide prepared in step (a). 12. The method of claim 11, wherein the pharmaceutical composition further comprises phosphate buffer in an amount sufficient to adjust the pH of the composition to a physiologically tolerable level. 13. The method of claim 11, wherein the pharmaceutical composition further comprises L-histidine. 14. The method of claim 11, wherein the pharmaceutical composition further comprises a bulking agent selected from the group consisting of mannitol and sucrose. 15. The method of claim 11, wherein the pharmaceutical composition is provided as an injectable dosage form."       
            },            
            "15563677": {
                "abstract": "The present invention provides a triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery including: a composite laparoscope for near infrared ray/gamma ray/visible ray acquisition configured to acquire triple images of a gamma ray from a gamma ray radioactive material injected to a diseased part, a visible ray, and a near infrared ray; an optical fiber configured to transmit the triple images acquired from the composite laparoscope; an optical source configured to generate a white light for acquiring a visible image through the optical fiber and a near infrared ray excitation light for acquiring a near infrared ray image by exciting a near infrared ray emitting fluorescence material at the disease part; an optical-to-electrical conversion module configured to separate individual images of the visible ray, near infrared ray and gamma ray from the triple images delivered through the optical fiber and then respectively convert the individual images to electrical signals; a matching unit configured to match a visible image signal, a near infrared image signal and a gamma ray image signal from the optical-to-electrical conversion module to one image; and an image display unit configured to display the image from the matching unit.",
                "claims": "A triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery comprising: a composite laparoscope for near infrared rat/gamma ray/visible ray acquisition configured to acquire triple images of a gamma ray from a gamma ray emitting radioactive material injected to a diseased part, a visible ray, and a near infrared ray; an optical fiber configured to transmit the triple images acquired from the composite laparoscope; an optical source configured to generate a white light for acquiring a visible image through the optical fiber and a near infrared ray excitation light for acquiring a near infrared ray image by exciting a near infrared ray emitting fluorescence material at the disease part; an optical-to-electrical conversion module configured to separate individual images of the visible ray, near infrared ray and gamma ray from the triple images delivered through the optical fiber and then respectively convert the individual images to electrical signals; a matching unit configured to match a visible image signal, a near infrared image signal and a gamma ray image signal from the optical-to-electrical conversion module to one image; and an image display unit configured to display the image from the matching unit. 2. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the composite laparoscope for near infrared rat/gamma ray/visible ray acquisition is configured from: a lens configured to focus the visible ray and the near infrared ray to a focal plane; a collimator configured to remove an unnecessary background gamma ray for gamma ray imaging or counting scheme, and for acquiring a wide field of view image; a gamma ray scintillation crystal configured to obtain a gamma ray scintillation image by an interaction with a gamma ray emitted from a radioactive material injected to the diseased part; and an optical mechanism by which the sensitivities and resolutions of the near infrared ray and gamma ray are adjustable by changing the distances between the components. 3. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 2, wherein the collimator is a diverging collimator, a parallel-hole collimator, or a single or multi-pinhole collimator. 4. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 3, wherein, when the collimator is a pinhole collimator and a diameter of the pinhole is D, a unique resolution of the gamma ray, point source sensitivities and sheet source sensitivities of the gamma ray, the near infrared ray and the visible ray are determined by prescribed equations. 5. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 4, wherein, in the pinhole collimator, a tungsten collimator is replaceable by another by using a rotary wheel, and 5 to 7 tungsten blades of which are assembled to freely adjust a diameter of a hole from 0.5 mm to 8 mm. 6. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the near infrared ray emitting fluorescence material is indocyanine green. 7. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the gamma ray radioactive material is a compound containing 99mTc. 8. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 7, wherein the compound containing 99mTc is 99mTc-antimony sulfide, 99mTc-sulfur colloid, 99mTc-nanocolloid, 99mTc-human serum albumin, or 99mTc-phytate colloid. 9. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 2, wherein the gamma ray scintillation crystal is GSO, BGO, or CsI(Tl). 10. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the optical-to electrical conversion module is configured from: a first dichroic mirror configured to separate a gamma ray scintillation in a 400 to 500 nm band from a light incident through the optical fiber; a first bandpass filter configured to pass only the gamma ray scintillation in the 400 to 500 nm band; a first CCD configured to convert the gamma ray scintillation in the 400 to 500 nm band to an electrical signal; a second dichroic mirror configured to separate a visible ray in a 500 to 700 nm band from a light passing through the first dichroic mirror; a second bandpass filter configured to pass only the visible ray in the 500 to 700 nm band; a second CCD configured to convert the visible ray in the 500 to 700 nm band to an electrical signal; and a third bandpass filter configured to pass only a near infrared ray in a 790 to 875 nm band from a light passing through the second dichroic mirror; and a third CCD configured to convert the near infrared ray in the 790 to 875 nm band to an electrical signal. 11. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the optical-to-electrical conversion module is configured from: one CCD; and a filter rotator configured from: a first bandpass filter configured to pass only a gamma ray scintillation in a 400 to 500 nm band; a second bandpass filter configured to only pass a visible ray in a 500 to 700 nm band; and a third bandpass filter configured to pass only an infrared ray in a 790 to 875 nm band. 12. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 1, wherein the matching unit, by being implemented with a computer (PC) configured to remove a noise so as to make each CCD image input from the optical-to-electrical conversion module have the same visual field, removes a noise for each frame of a gamma ray signal image incident to a first CCD with a median filter, and a total brightness value and a number of pixels having a value equal to or greater than a threshold value calculated in advance are calculated to be available as a real time counting mode. 13. The triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery according to claim 2, further comprising: a fiber optic taper configured to deliver the visible ray image, near infrared ray image, and the gamma ray image to the optical fiber."
            },            
            "15624296": {
                "abstract": "A method of separating a multiphase fluid, the fluid including a relatively high density component and a relatively low density component, that includes introducing the fluid into a separation region; imparting a rotational movement into the multiphase fluid; forming an outer annular region of rotating fluid of predetermined thickness within the separation region; and forming and maintaining a core of fluid in an inner region. Fluid entering the separation vessel is directed into the outer annular region and the thickness of the outer annular region is such that the high density component is concentrated and substantially contained within this region, the low density component being concentrated in the rotating core. A separation system employing the method is also provided. The method and system are particularly suitable for the separation of solid debris from the fluids produced by a subterranean oil or gas well at wellhead flow pressure.",
                "claims": "A subsea processing assembly comprising: a wellhead assembly through which fluids are produced from a subterranean well; a separator assembly comprising a fluid inlet connected to the wellhead assembly for receiving fluids produced from the well, the separator assembly being operable at well pressure to remove well debris entrained in the fluids to produce a solids rich phase and a fluid phase, the separator assembly comprising a fluid outlet for the fluid phase; and a choke assembly comprising an inlet connected to the fluid outlet of the separator assembly. 2. The processing assembly of claim 1, wherein the separator assembly is located subsea. 3. The processing assembly of claim 1, wherein the separator assembly is located on a platform, the processing assembly further comprising: a fluid receiving assembly for receiving fluids produced from a subterranean well, the separator assembly comprising a fluid inlet connected to the fluid receiving assembly for receiving the fluids produced from the well. 4. A processing assembly comprising: a fluid receiving assembly for receiving fluids produced from a subterranean well; a separator assembly comprising a fluid inlet connected to the fluid receiving assembly for receiving fluids produced from the well, the separator assembly being operable at well pressure to remove well debris entrained in the fluids to produce a solids rich phase and a fluid phase, the separator assembly comprising a fluid outlet for the fluid phase; and a choke assembly comprising an inlet connected to the fluid outlet of the separator assembly. 5. The processing assembly of claim 4, further comprising a wellhead assembly through which fluids are produced from the subterranean well. 6. The processing assembly of claim 4, wherein the wellhead assembly is located subsea. 7. The processing assembly of claim 4, wherein the separator assembly is located on a platform."            
            },            
            "15624084": {
                "abstract": "A system and method displays information using a vehicle-mount computer. The system includes (i) an input device and a display device for inputting and displaying information; (ii) a motion detector for detecting vehicle motion; (iii) a proximity sensor for detecting proximity to an item; and (vi) a vehicle-mount computer in communication with the input device, the display device, the motion detector, and the proximity sensor, the vehicle-mount computer including a central processing unit and memory. The vehicle-mount computer's central processing unit is configured to store information associated with user-selected information from the input device and to display a zoomed view of the user-selected information on the display device. Further, the vehicle-mount computer's central processing unit is configured to override screen-blanking when user-selected information is displayed.",
                "claims": "A system comprising: a memory; an input unit; a display unit; a motion detector; a processing unit coupled to the memory, the input unit, the display unit, and the motion detector, wherein the processing unit is configured to: store user-selected information corresponding to information selected by a user via the input unit from amongst items displayed on the display unit and wherein the user-selected information is indicative of the information to be displayed on the display unit when the motion detector detects a motion; access motion information from the motion detector; identify, upon accessing motion information, no user-selected information being stored in the memory and based on the identification control the display unit to blank all of the items to be displayed on the display unit; and determine, upon accessing motion information, the user-selected information being stored in the memory and based on the determination control the display unit to override blanking of the all the items on the display unit and display user-selected information on the display unit. 2. The system of claim 1, wherein the processing unit is configured to control the display unit for displaying a zoomed view of the user-selected information. 3. The system of claim 2, wherein the zoomed view covers at least about 50% of display area of the display unit. 4. The system of claim 2, wherein the processing unit is configured to control the display unit for displaying a zoomed view of the user-selected information and additional information associated with the user-selected information in response to detection of motion by the motion detector. 5. The system of claim 1, wherein the user-selected information is one of: a navigational aid, an assistive information corresponding to picking of an item, and a zoomed view of textual information to be displayed on the display unit when the motion detector detects the motion. 6. The system of claim 1, comprising a proximity sensor; wherein the processing unit is configured to receive location information from the proximity sensor; and wherein, in response to location information, the processing unit is configured to display on the display device additional information associated with the user-selected information. 7. The system of claim 1, wherein the user-selected information is within a user-selected area on the display unit and wherein the user-selected area comprises any one of a circle and a rectangle encompassing information to be displayed on the display unit. 8. The system of claim 1, wherein configuration of the display unit for the user-selected area is predetermined by the processing unit. 9. The system of claim 1, wherein the motion detector comprises an accelerometer, a gps locator, a gyroscope, and/or a compass. 10. A method comprising: monitoring motion associated with one of a computing system and a vehicle with a motion detector; determining an availability of user-selected information corresponds to information selected by a user, the information from amongst items to be displayed on a display unit and wherein the user-selected information is indicative of the information to be displayed on the display unit when the motion detector detects a motion; blanking all the items to be displayed on the display unit in response to the detection of motion if the user-selected information is determined to be not available; overriding blanking all of the items to be displayed on the display unit and displaying the user-selected information in response to the detection of motion if the user-selected information is determined to be available. 11. The method of claim 10, comprising displaying one of: a navigational aid, an assistive information corresponding to picking of an item, and a zoomed view of textual information to be displayed on the display unit when the motion detector detects the motion. 12. The method of claim 10, comprising supplementing information displayed on the display unit with additional information, based on the detection of the motion by the motion detector. 13. The method of claim 10, comprising selecting an area on the display unit for providing the user-selected information and wherein the provided user-selected information is to be displayed in a zoomed view on the display unit upon detection of the motion by the motion detector. 14. The method of claim 10, comprising: receiving, from a proximity sensor, location information corresponding to an object; and displaying, in response to location information, on the display device additional information associated with the user-selected information. 15. A non-transient computer readable medium comprising instructions executable by a processing unit to perform the steps of: monitoring motion associated with a computing system by a motion detector; determining an availability of user-selected information corresponding to information selected by a user, the information from amongst items to be displayed on a display unit and wherein the user-selected information is indicative of the information to be displayed on the display unit when the motion detector detects a motion; blanking all the items to be displayed on the display unit in response to the detection of motion if the user-selected information is determined to be not available; overriding blanking of all the items to be displayed on the display unit and displaying the user-selected information in response to the detection of motion if the user-selected information is determined to be available. 16. The non-transient computer readable medium of claim 15, comprising instructions executable by the processing unit for displaying one of: a navigational aid, an assistive information corresponding to picking of an item, and a zoomed view of information to be displayed on the display unit when the motion detector detects the motion. 17. The non-transient computer readable medium of claim 15, comprising instructions executable by the processing unit for supplementing information displayed on the display unit with additional information based on the detection of the motion by the motion detector. 18. The non-transient computer readable medium of claim 15, comprising instructions executable by the processing unit for selecting an area on the display unit for providing the user-selected information and wherein the provided user-selected information is to be displayed in a zoomed view on the display unit upon detection of the motion by the motion detector. 19. The non-transient computer readable medium of claim 15, comprising instructions for: receiving from a proximity sensor, location information corresponding to an object; and displaying, in response to location information, on the display device additional information associated with the user-selected information 20. The non-transient computer readable medium of claim 15, comprising instructions for displaying a zoomed view of the user-selected information on the display unit in response to the detection of the motion if the user-selected information is determined to be available."            
            },            
            "11913160": {
                "abstract": "The invention is a method and composition for treating biofilm using a high valency silver ion. In preferred embodiments of the invention, the anti-biofilm agent is used to preserve, disinfect or treat plant material, including seeds, leaves, stems, vessels, flowers, roots and fruits, and any surface, particularly disinfecting work or processing surfaces and seed or plant surfaces; in anti-microbial coatings; and in treating human, plant, and animal diseases and conditions",
                "claims": "A method for treating microorganisms comprising contacting the microorganism with a composition that comprises at least one preservative agent, said preservative agent comprising a high valency silver ion. 2. The method claim 1 wherein said composition comprises: an aqueous solution of silver nitrate; an oxidizing agent; and anions of at least one acid 3. (canceled) 4. The method of claim 1 wherein treating the microorganism comprises treating against one or more biofilms. 5. The method of claim 4 wherein treating the microorganism against one or more biofilms comprises eradicating or reducing the biofilm. 6. The method of claim 4 wherein treating against one or more biofilms comprises treating against one or more species selected from the group consisting of Erwinia species, Pseudomonas species, Xanthomonas species, Clavibacter species, Curtobacterium species, Streptomyces species, Fusarium species, Rhizoctonia species, Colletotrichum species, Verticillium species, Pythium species, Phythophthora species, Helminthosporium species, Sclerotinia species, Botrytis species, Ascochyta species, and variants thereof. 7. A method of treating microorganisms comprising contacting the microorganism with an anti-biofilm agent, wherein said anti-biofilm agent comprises a silver deposition compound. 8. The method of claim 7 wherein said anti-biofilm agent comprises a high valency silver ion, and mixtures thereof. 9. The method of claim 7 wherein the biofilm is located on or in a plant or portion thereof, or a natural or man-made surface material associated with the production, transport, handling, processing or packaging of a plant commodity. 10. The method of claim 7 wherein the biofilm is located on or in an animal or portion thereof, or a natural or man-made surface material associated with the growth, transport, handling, processing or packaging of an animal commodity. 11. The method of claim 7 wherein the biofilm is located on or in a medical device or portion thereof, or a natural or man-made surface material associated with the production, transport, handling, processing or packaging of said device. 12. The method of claim 7 wherein the biofilm is located on or in a industrial machine or surface or portion thereof. 13. The method of claim 7 further comprising at least one additional anti-biofilm agent. 14. The method of claim 7 wherein said anti-biofilm agent further comprises treating planktonic bacteria. 15. An anti-microbial composition comprising a composition comprising high valency silver ions." 
            },       
            "13261853": {
                "abstract": "A mailing device (10) comprises a blank (12) of foldable material defining at least two panels (14, 16) separated by one or more fold lines (18). At least two of the panels (14, 16) have removable edge regions (24, 26, 30) and an inner surface of the removable edge regions of a first of the panels (14) is coated with adhesive to enable the edge regions to be bonded to corresponding removable edge regions of another panel when the blank is folded. A sheet of material (36) is affixed to an inner surface of one of the panels (14) so as to cover an inner region of the panel within the removable edge regions. The sheet (36) may be printed on with a security hatching. Releasable tape (34) may be applied over the adhesive and the sheet (36) may be made of the same material as the release tapes. Various other mailing devices are also disclosed.",
                "claims": "A mailing device comprising a blank of foldable material defining at least two panels separated by one or more fold lines, at least two of the panels having removable edge regions defined by means of lines of weakness in the blank, an inner surface of the removable edge regions of a first of the panels having adhesive to enable the edge regions of said first panel to be bonded to corresponding removable edge regions of another panel when the blank is folded, wherein a sheet of material is affixed to an inner surface of one of the panels so as to cover at least an inner region of the panel within the lines of weakness. 2. A mailing device as claimed in claim 1, wherein the sheet is printed on. 3. A mailing device as claimed in claim 2, wherein the sheet is printed on with a security hatching or other security pattern. 4. A mailing device as claimed in any one of claims 1 to 3, wherein the sheet of material is affixed to the first panel, the adhesive on the removable edge regions of the first panel being covered by one or more release tapes made of the same material as the sheet. 5. A mailing device as claimed in claim 4, wherein the one or more tapes of liner and the sheet are formed from a single piece of die cut material. 6. A mailing device as claimed in claim 4 or claim 5, wherein the sheet extends beyond the lines of weakness defining at least two removable edge regions of the first panel so that peripheral portions of the sheet are affixed to the removable edge regions by means of the adhesive thereon. 7. A mailing device as claimed in any one of the preceding claims, in which the first panel has three removable edge regions, two of the removable edge regions being provided along opposite sides of the first panel and a third removable edge region extending along an end of the first panel interconnecting the sides, the adhesive on all three of the edge regions being covered by a single, continuous, generally U shaped tape of liner material. 8. A mailing device as claimed in any one of claims 1 to 7, wherein the blank defines two panels foldably connected by a first fold line, each of the panels having three removable edge regions, two of the removable edge regions being provided along opposite sides of each respective panel and a third removable edge region extending along an end of the respective panel opposite from the first fold line. 9. A mailing device as claimed in any one of claims 1 to 7, comprising a first and second panel connected by way of a first fold line, and a third panel connected to the second panel by way of a second fold line, the third panel being connected to an end of the second panel opposite the end connected to the first panel, wherein each of the panels comprise removable edge regions extending longitudinally along opposite sides of the first, second and third panels to form removable side edge regions, wherein first and second transverse lines of weakness extend respectively across the first panel and the second panel parallel to and equi-spaced from the first fold line to form removable end edge regions, and wherein the removable edge regions of said second panel are provided with a plurality of apertures, the arrangement being such that the first and third panels overlay the second panel on opposite sides thereof, the third panel being bonded to the first panel by way of said adhesive exposed through said apertures, when the blank is folded. 10. A mailing device as claimed in claim 9, wherein a transverse line of weakness extends substantially parallel to the free end of the third panel, said line of weakness extending between opposing side edges of the third panel or between said side edge regions of the third panel. 11. A method of manufacturing a mailing device as claimed in any one of claims 1 to 10, the method comprising: applying adhesive to the removable edge regions of the first panel portion, positioning a single planer piece of liner material over inner surface of the first panel covering substantially the whole of the first panel including at least those parts of the removable edge portions to which adhesive has been applied, and kiss cutting the piece of material to define the inner sheet and one or more removable tapes of liner material covering the adhesive on the removable edge regions of the first panel. 12. A method of manufacturing a mailing device as claimed in claim 11, wherein the method comprises kiss cutting the liner material at positions just outside the lines of weakness within the zones of adhesive applied to the removable edge regions so that peripheral edge portions of the sheet overlay part of the adhesive. 13. A mailing device comprising a blank of foldable material defining a first panel, a second panel foldably connected to a first end of the first panel by means of a first fold line, and a closure flap foldably connected to a second end of the first panel opposite the first end by means of a second fold line, wherein first and second transverse lines of weakness extend respectively across the first panel and the closure flap parallel to and equi-spaced from the second fold line, at least part of an outer end region of the cover flap on the opposite side of the second line of weakness from the second fold line having an adhesive on its inner surface, the arrangement being such that the outer end region of the cover flap overlays and can be bonded to an outer face of the second panel in when the blank is folded. 14. A mailing device as claimed in claim 13, wherein the second panel is dimensioned so that when folded about the first line, an end of the second panel opposite from the first fold line is positioned proximal to but on the opposite side of the first transverse line of weakness from the second fold line. 15. A mailing device as claimed in claim 13 or claim 14, wherein longitudinal lines of weakness extend along either side of the blank to define removable side edge regions of the first and second panels and the closure flap. 16. A mailing device as claimed in claim 15, wherein the first and second transverse lines of weakness extend across the first panel and the cover flap respectively between the longitudinal lines of weakness. 17. A mailing device as claimed in claim 15 or claim 16, wherein adhesive is applied to inner surfaces of the removable side edge regions of the first panel and the cover flap. 18. A mailing device as claimed in claim 17, wherein the adhesive on the removable side edge regions of the first panel and the cover flap and the outer edge region of the cover flap is covered by one or more releasable tapes of liner material. 19. A mailing device as claimed in any one of claims 15-18, wherein a sheet of material is affixed to the blank so as to substantially cover the inner surface of at least an inner region of the first panel within the longitudinal and first transverse lines of weakness. 20. A mailing device as claimed in claim 19 when dependent on claim 18, wherein the sheet of material covering the inner region of the first panel is made from the same material as the one or more releasable tapes of liner material covering the adhesive on the removable edge regions of the first panel and cover flap. 21. A mailing device as claimed in claim 20, wherein the one or more tapes of liner material and the sheet are formed from a single piece of die cut material. 22. A mailing device as claimed in any one of claims 19 to 21, wherein the sheet is printed on. 23. A mailing device as claimed in claim 22, wherein the sheet is printed on with a security hatching or other security pattern. 24. A mailing device comprising a blank of foldable material defining at least two panels separated by fold lines, at least one of the at least two panels having removable edge regions defined by means of lines of weakness in the blank, a first of the panels having edge regions that contact corresponding removable edge regions of a further one of the panels when the mailer is folded, an inner surface of the edge regions of one of the first and the further one of the panels having an adhesive for bonding the corresponding removable edge regions together when the blank is folded, a tear strip being affixed to the edge regions of the first panel, the tear strip having a tab portion at one end, the blank having an opening in the further panel which overlays the tab portion when the blank is folded to allow access to the tab portion. 25. A mailing device as claimed in claim 24, wherein the adhesive is applied to the edge regions of the first of the panels and a tape of releasable liner material covers the adhesive on the edge regions of the first panel outside the tear strip. 26. A mailing device as claimed in claim 25, wherein the tape of releasable liner material and the tear strip are made of the same material. 27. A mailing device as claimed in claim 25, wherein the tape of releasable liner material and the tear strip are formed from a single piece of die cut material. 28. A mailing device as claimed in any one of claims 24 to 27, wherein the tear strip is positioned so as to align with the line of weakness in the blank defining the at least one removable edge region of the other panel when the mailing device is folded. 29. A mailing device as claimed in claim 28, wherein which an inner edge of the tear strip is positioned to align with the line of weakness in the blank defining the at least one removable edge region of the other panel when the mailing device is folded. 30. A mailing device as claimed in claim 28, wherein the other panel has removable edge regions defined along both sides and along one end, the tear strip being substantially U or horseshoe shaped to align with the lines of weakness defining the three removable edge regions in the other panel when the blank is folded. 31. A mailing device as claimed in any one of claims 24 to 30, wherein the tear strip material has a greater tear resistance than the material of the blank. 32. A mailing device as claimed in claim 25, or any one of claims 26 to 31 when dependent on claim 25, wherein the tape of releasable liner material has a width in the range of 4 mm to 6 mm and the inner tear strip portion has a width of 1 mm to 3 mm. 33. A mailing device as claimed in claim 15, or any one of claims 26 to 32 when dependent on claim 25, wherein adhesive is applied in strips along the edge regions of the first panel, the outer portion of the tape of releasable liner material overlaying an outer portion of the strips and the tear strip portion overlying an inner portion of the strips. 34. A mailing device as claimed in claim 25, or any one of claims 26 to 33 when dependent on claim 25, wherein the first panel has edge regions defined along both sides and along one end opposite the first fold line, adhesive being applied to an inner surface of the three edge regions of the first panel, the tape of releasable liner material and the tear strip each comprising a single continuous length of releasable liner material having a generally U shape and extending about all three of the edge regions of the first panel. 35. A mailing device as claimed in any one of claims 24 to 34, wherein the edge regions of the first panel are removable edge regions defined by lines of weakness in the blank. 36. A method of manufacturing a mailing device as claimed in any one of claims 24 to 35, the method comprising: applying adhesive to the edge regions of the first panel portion, positioning a single planer piece of releasable liner material over inner surface of the first panel covering substantially the whole of the first panel including at least those parts of the edge portions to which adhesive has been applied, kiss cutting the liner material to define inner and outer edges of the tear strip. 37. A method as claimed in claim 36, the method further comprising removing the portion of liner material inside the tear strip. 38. A mailing device comprising a blank of foldable material defining a first and second panel connected by way of a first fold line, and defining a third panel connected to the second panel by way of a second fold line, the third panel being connected to an end of the second panel opposite the end connected to the first panel, the panels having removable side edge regions defined by means of lines of weakness formed longitudinally along either side of the blank, an inner surface of the removable edge regions of the first panel having adhesive to enable the edge regions of said first panel to be bonded to corresponding removable edge regions of the second panel when the blank is folded, wherein first and second transverse lines of weakness extend respectively across the first panel and the second panel parallel to and equi-spaced from the first fold line to form removable end edge regions, and wherein the removable edge portions of said second panel are provided with a plurality of apertures, the arrangement being such that the first and third panels overlay the second panel on opposite sides thereof, the third panel being bonded to the first panel by way of said adhesive exposed through said apertures, when the blank is folded. 39. A mailing device as claimed in claim 38, wherein a further transverse line of weakness extends substantially parallel to the free end of the third panel, said line of weakness extending between opposing side edges of the third panel or between said side edge regions of the third panel. 40. A mailing device as claimed in claim 39, wherein the adhesive on the removable side edge regions of the first panel is covered by one or more releasable tapes of liner material."
            },
            "14117237": {
                "abstract": "The invention relates to an operating cylinder which includes a cylinder liner having one or more annular grooves incorporated into it, corresponding retainer rings or retainer ring segments fitting into said grooves and resting against the bulkheads or being forced against the cylinder liner or against the retainer rings or the retainer ring segments by means of the shaft nut owing to the beveled or fluted section. Means prevent any additional axial displacement of the bulkheads.",
                "claims": "An operating cylinder wherein the operating cylinder comprises a cylinder liner in which are disposed one or a plurality of interior or exterior annular grooves or beads that accommodate retainer rings or retainer ring segments, which rest against the bulkheads that include a beveling or fluting, or in that the bulkheads are forced against the retainer rings or the retaining ring segments by means of the shaft nut, and in that the shaft nut presses against the retainer rings, or in that the shoulder 6a presses against the shoulder edge of the cylinder liner, or in that the retainer rings are disposed against the inner diameter of the bulkheads spreading themselves apart, due to the nut being screwed onto the thread, and being forced into the annular groove, and in that by means of the shaft nut or cap or axial snap ring any axial displacement of the bulkheads toward the inside of the operating cylinder is prevented, or in that a snap retaining ring on the bulkhead prevents any outward axial displacement of the bulkhead. 2. The operating cylinder according to claim 1, wherein the bulkheads comprise further technical means, which are a radial seal and a fluid inlet piping connection and piston rod bore and sealing groove and/or longitudinal groove and/or bead and/or fluid bores and/or thread and/or air filter means or bellows and/or measurement means and/or lift lock and/or final layer dampening. 3. The operating cylinder according to claim 2, wherein the fluting approximately corresponds to the cross-sectional profile of the round wire of the retainer ring, and/or in that the respective annular groove is hollow turned or rotary pressed corresponding approximately to the cross-sectional profile of the round wire of the retainer ring. 4. The operating cylinder according to claim 1, wherein the serially inserted retainer rings have diverging clamping forces. 5. The operating cylinder according to claim 1, wherein a plurality of annular grooves are disposed on each side of the cylinder liner that have retainer rings inserted therein, and in that an intermediate piece is disposed between these retainer rings, respectively. 6. The operating cylinder according to claim 1, wherein a collar and a bead are formed on the exterior of the cylinder liner. 7. The operating cylinder according to claim 1, wherein the operating cylinder is a fluid cylinder or an electric spindle cylinder or an accumulator means in form of a membrane, bladder or piston accumulator. 8. The operating cylinder according to claim 1, wherein the operating cylinder constitutes a telescopic cylinder including one or a plurality of telescopic piston rods."
            }
        }

state = SessionState()

# Define the function to calculate the patentability score
@st.cache_data()
def calculateScore(patent_id, abstract, claims):
    inputs = tokenizer(abstract, claims, padding=True, truncation=True, max_length=512, return_tensors='pt')
    outputs = model(**inputs)
    logits = outputs.logits
    scores = logits.softmax(dim=1).tolist()[0]
    score, idx = np.max(scores), np.argmax(scores)
    certainty = score*100
    decision = 'Patentable' if idx==1 else 'Not Patentable'
    return {'Abstract': abstract, 'Claims': claims, 'Decision': decision, 'Certainty': certainty}


# Define the patent IDs
patentIds = ["9950112", "9604242", "9660732", "9782455", "15563677",
              "15624296", "15624084", "11913160", "13261853", "14117237"]

# Define the dropdown menu for the patent ID
selectedPatentId = st.selectbox("Select Patent ID", patentIds)

# Autofill the Abstract and Claims text boxes based on the selected patent ID
if selectedPatentId != "":
    abstractText = state.patentData[selectedPatentId]["abstract"]
    claimsText = state.patentData[selectedPatentId]["claims"]
else:
    abstractText = ""
    claimsText = ""

# Define the text area widgets for abstract and claims
abstractText = st.text_area("Abstract", height=200, value=abstractText)
claimsText = st.text_area("Claims", height=200, value=claimsText)

# Define the submit button for patent ideas and scores
if st.button("Submit"):
    if not abstractText.strip() or not claimsText.strip():
        st.write("Please enter the abstract and claims.")
    else:
        scoreData = calculateScore(selectedPatentId, abstractText, claimsText)
        patentData = {'Abstract': abstractText, 'Claims': claimsText, 'Score': scoreData}
        state.patentData[selectedPatentId] = patentData
        st.write("Patent ID:", selectedPatentId)
        st.write("Abstract:", abstractText)
        st.write("Claims:", claimsText)
        st.write("Patentability Score:", scoreData['Decision'])
        st.write("Certainty (%):", scoreData['Certainty'])